Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Somatostatin Analogs Companies

Somatostatin analogs are synthetic compounds that mimic the action of somatostatin, a naturally occurring hormone that regulates various physiological functions, including the inhibition of growth hormone release. These analogs are used in the treatment of conditions such as acromegaly, neuroendocrine tumors, and certain gastrointestinal disorders.

Somatostatin Analogs Key Companies

Latest Somatostatin Analogs Companies Update:

Novartis (Switzerland) Received FDA approval for Signifor® (pasireotide) LAR, a long-acting injectable for treating adults with acromegaly, offering bi-monthly dosing convenience. Continued research on Signifor® for potential applications in other hormonal disorders like Cushing's syndrome.

Ipsen (France) Collaborated with Roche to develop and commercialize a first-in-class oral somatostatin receptor agonist for acromegaly, potentially offering a non-injectable treatment option. Focused on expanding their Somatropin portfolio and strengthening their presence in the NETs treatment market.

Sun Pharmaceutical Industries Ltd. (India) Launched their affordable generic versions of somatostatin analogs, increasing access to treatment in resource-limited settings. Partnered with research institutions to explore the potential of somatostatin analogs for treating hormonal imbalances and metabolic disorders.

European Neuroendocrine Tumor Society (ENETS) Updated their treatment guidelines for NETs, highlighting the evolving role of somatostatin analogs and personalized therapy approaches. Provided educational resources and patient advocacy programs to raise awareness about NETs and improve diagnosis and treatment options.

National Cancer Institute (NCI) Funded research on the use of somatostatin analogs in combination with other therapies for cancer treatment, aiming to improve efficacy and reduce side effects. Supported studies on developing targeted delivery systems for these drugs to optimize their action and minimize systemic exposure.

List of Somatostatin Analogs Key companies in the market

Novartis AG (Switzerland)

Ipsen Pharma (France)

Fresenius Kabi (Germany)

Peptron (South Korea)

Pfizer Inc. (US)

Teva Pharmaceuticals Inc. (Israel)

Somatostatin Analogs Market Highlights:

Somatostatin Analogs Market Size

Somatostatin Analogs Market Trends

Somatostatin Analogs Market Analysis

Somatostatin Analogs Market Share

Somatostatin Analogs Market Highlights:

Somatostatin Analogs Market Trends

Somatostatin Analogs Market Analysis

Somatostatin Analogs Market Share

Somatostatin Analogs Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.